| 中文名称： |
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇 |
| 中文别名： |
恩替卡韦中间体N5; 恩替卡韦-5; 恩替卡韦中间体5; E5; (2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇(N5) |
| 英文名称： |
(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol |
| 英文别名： |
(2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-a(benzyloxymethyl)cyclopentanol; (2R,3S,5S)-3-(Benzyloxy)-5-(6-benzyloxy)-2-(4-methyoxyphenyl)diphenylmethylamino)-9H-purin-9-yl)-2-benzyloxymethyl)cyclopentanol; Entecavir intermediate N5; (1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-((4-methoxyphenyl)diphenylmethylamino)-9H-purin-9-yl)-2-((4-methylbenzyloxy)methyl)cyclopentanol; Entecavir intermediate 5; Intermediate of Entecavir 3; (1S,2S,3S,5S)-3-(benzyloxy-5-(6-(benzyloxy)-2-(diphenyl(p-tolylamino)methylamino)-1H-purin-9(6H)-yl-2-(benzyloxymethyl)cyclopentanol; (2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl)diphenylmethyl]amino]-6-(phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol (E5); E5; (2R,3S,5S)-3-(Benzyloxy)-5-[2-[[(4-methoxyphenyl) diphenylmethyl]amino]-6- (phenylmethoxy)-9H-purin-9-yl]-2-(benzyloxymethyl)cyclopentanol; (1S,2S,3S,5S)-3-(benzyloxy)-5-(6-(benzyloxy)-2-(((4-methoxyphenyl)diphenylmethyl)amino)-9H-purin-9-yl)-2-((benzyloxy)methyl)cyclopentanol |
| CAS号： |
142217-78-5 |
| 分子式： |
C52H49N5O5 |
| 分子量： |
823.98 |
| InChI： |
InChI=1/C52H49N5O5/c1-59-43-29-27-42(28-30-43)52(40-23-13-5-14-24-40,41-25-15-6-16-26-41)56-51-54-49-47(50(55-51)62-34-39-21-11-4-12-22-39)53-36-57(49)45-31-46(61-33-38-19-9-3-10-20-38)44(48(45)58)35-60-32-37-17-7-2-8-18-37/h2-30,36,44-46,48,58H,31-35H2,1H3,(H,54,55,56)/t44-,45-,46-,48?/m0/s1 |
| 分子结构： |
![(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇 142217-78-5](https://images-a.chemnet.com/suppliers/chembase/cas/cas142217-78-5.gif)
|
KR
CZ
DE
ES
FR
GR
HU
ID
IN
IL
IR
IT
JP
MY
NL
NO
PL
PT
RU
SA
TR
产品分类浏览